Увійти

Готові списки джерел за темами / Anti-novel / Статті в журналах

Статті в журналах з теми "Anti-novel"

Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: Anti-novel.

Автор: Grafiati

Опубліковано: 10 грудня 2022

Оновлено: 29 січня 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Anti-novel".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Tadd Adcox, James. "The Anti-Novel." American Book Review 37, no. 4 (2016): 24–25. http://dx.doi.org/10.1353/abr.2016.0060.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Anil Castelino, Prakash, Dr Jagadeesh Prasad Dasappa, Dr Prashantha Naik, Sharath Chandra K., and Anusha Kumari G. Y. "Mosquito-Larvicidal, Anti-Bacterial and Anti-Fungal Properties of Novel 2, 4-Disubstituted-[1, 3] - Thiazoles." Indian Journal of Applied Research 4, no. 3 (October 1, 2011): 25–31. http://dx.doi.org/10.15373/2249555x/mar2014/9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Chaban, T. I., V. S. Matiychuk, V. V. Ogurtsov, I. G. Chaban, and I. A. Nektegayev. "Development of effective anti-inflammatory drug candidates among novel thiazolopyridines." Ukrainian Biochemical Journal 92, no. 2 (April 17, 2020): 132–39. http://dx.doi.org/10.15407/ubj92.02.132.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Chang, M. H., H. Y. Koh, Y. S. Cho, and K. I. Choi. "Novel Anti-Pseudomonas Cephalosporins." Current Pharmaceutical Design 3, no. 2 (April 1997): 209–26. http://dx.doi.org/10.2174/138161280302221006120722.

Повний текст джерела

Анотація:

Abstract: Since the catechol type cephalosporins having a potent activity against P. aeruginosa strain were introduced, many kinds of derivatives have been developed. These cephalosporins adopted various substituents as siderophores such as catechol or pyridone type derivatives at C-7 or C-3 position to facilitate their penetration through the bacterial cell membrane. In this review, the structural specifications of the recently developed cephalosporins and their biological activity against P. aeruginosa bacterial strain would be overviewed.

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Kitto, GB. "Novel anti-AIDS immunotoxins." Biofutur 1997, no. 163 (January 1997): 44. http://dx.doi.org/10.1016/s0294-3506(97)89240-x.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Naher, Prof Dr Habeeb Sahib, and Prof Anwar Kadhim AL-Saffar. "Novel Anti- tuberculosis Compound." IOSR Journal of Pharmacy and Biological Sciences 9, no. 5 (2014): 01–05. http://dx.doi.org/10.9790/3008-09510105.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Lohray, Vidya B., Braj B. Lohray, and Brijesh Kumar Srivastava. "Novel anti-infective compounds." Pure and Applied Chemistry 77, no. 1 (January 1, 2005): 195–200. http://dx.doi.org/10.1351/pac200577010195.

Повний текст джерела

Анотація:

A set of substituted piperazinyloxazolidinone derivatives has been studied for their antibacterial activity in a few gram-positive bacteria. The structural modifications have provided a superior compound than linezolid, the only drug of this class in the market at present.

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Proietto, Joseph, Barbara C. Fam, Deborah A. Ainslie, and Anne W. Thorburn. "Novel anti-obesity drugs." Expert Opinion on Investigational Drugs 9, no. 6 (June 2000): 1317–26. http://dx.doi.org/10.1517/13543784.9.6.1317.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Chandraprabha, V. J. "Novel Thiazoles Derivatives Containing Methoxy-Napthyl Moiety as Potent Anti-Bacterial and Anti-Tubercular Agents and Its Characterization." Journal of Medical Science And clinical Research 04, no. 11 (November 10, 2016): 13759–68. http://dx.doi.org/10.18535/jmscr/v4i11.42.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Guan, Y. J., J. C. Wang, J. Hu, Y. X. Tian, W. M. Hu, and S. J. Zhu. "A novel fluorescent dual-labeling method for anti-counterfeiting pelleted tobacco seeds." Seed Science and Technology 41, no. 1 (April 1, 2013): 158–63. http://dx.doi.org/10.15258/sst.2013.41.1.18.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Cistelecan, Alex. "Novel and Anti-Novel. Moretti Before Distant Reading." Metacritic Journal for Comparative Studies and Theory 6, no. 2 (December 10, 2020): 5–22. http://dx.doi.org/10.24193/mjcst.2020.10.01.

Повний текст джерела

Анотація:

The paper discusses an intermediary phase in Franco Moretti’s intellectual journey, namely the years 1990s. This is a period of transition in Moretti’s thinking, in which he is working simultaneously on two fronts: on the one hand, he is refining evermore and bringing to completion his specific brand of close reading analysis developed in the previous decade – namely the combination of evolutionary theory, formal-rhetorical analysis, and eclectic Marxism (with its highly unstable mix of Lukács, Wallerstein, and Della Volpe); on the other, he is forging for the first time the new tools and concepts of what will become, after 2000, his defining intellectual signature – the method of distant reading. The two undertakings correspond to two opposed literary objects: on the one hand, the novel – with its regularity of form, reproduction in large scale, centripetal movement, bourgeois imaginary, and national horizon; on the other, what we call the ‘anti-novel’, which is the modern epic in Moretti’s understanding – the few dozen ‘world-texts’, highly polymorphous and reproducible only in few and select occurrences, centrifugal in their movement, and transcending the national and bourgeois horizon, rooted as they are in the critical, semi-peripheral junctures of the capitalist world-system. The paper dwells on some of the oppositions and similarities, overlaps and contradictions, theoretical problems and practical solutions, raised or offered by the two methodological approaches and their corresponding literary objects.

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Shahid, Sukhbir K. "Novel anti-Helicobacter pylori therapies." Pharmaceutical Patent Analyst 3, no. 4 (July 2014): 411–27. http://dx.doi.org/10.4155/ppa.14.27.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

13

Kyme, Christine. "Novel target for anti-epileptics." Nature Clinical Practice Neurology 1, no. 2 (December 2005): 66–67. http://dx.doi.org/10.1038/ncpneuro0022.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

14

Jones, Kellie L., and Aman U. Buzdar. "Evolving novel anti-HER2 strategies." Lancet Oncology 10, no. 12 (December 2009): 1179–87. http://dx.doi.org/10.1016/s1470-2045(09)70315-8.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

15

Feng, Fei, Nobuaki Miura, Norikazu Isoda, Yoshihiro Sakoda, Masatoshi Okamatsu, Hiroshi Kida, and Shin-Ichiro Nishimura. "Novel trivalent anti-influenza reagent." Bioorganic & Medicinal Chemistry Letters 20, no. 12 (June 2010): 3772–76. http://dx.doi.org/10.1016/j.bmcl.2010.04.060.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Wang, Guiseng, Daoyong Chen, Lude Lu, Xin Wang, and Yu Yang. "A novel anti-condensation coating." Journal of Coatings Technology 70, no. 8 (August 1998): 55–59. http://dx.doi.org/10.1007/bf02720520.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Chen, Wangxue, Chi-Hui Cho, and Vinton S. Chadwick. "Novel anti-Helicobacter pylori agents." Expert Opinion on Therapeutic Patents 10, no. 8 (August 2000): 1221–32. http://dx.doi.org/10.1517/13543776.10.8.1221.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Prakash, A., K. S. Babu, and J. B. Morjaria. "Novel anti-cholinergics in COPD." Drug Discovery Today 18, no. 21-22 (November 2013): 1117–26. http://dx.doi.org/10.1016/j.drudis.2013.07.005.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Choi, Yae Rim, Jaewon Shim, and Min Jung Kim. "Genistin: A Novel Potent Anti-Adipogenic and Anti-Lipogenic Agent." Molecules 25, no. 9 (April 27, 2020): 2042. http://dx.doi.org/10.3390/molecules25092042.

Повний текст джерела

Анотація:

Soy isoflavones are popular ingredients with anti-adipogenic and anti-lipogenic properties. The anti-adipogenic and anti-lipogenic properties of genistein are well-known, but those of genistin and glycitein remain unknown, and those of daidzein are characterized by contrasting data. Therefore, the purpose of our study was to investigate the effects of daidzein, glycitein, genistein, and genistin on adipogenesis and lipogenesis in 3T3-L1 cells. Proliferation of 3T3-L1 preadipocytes was unaffected by genistin and glycitein, but it was affected by 50 and 100 µM genistein and 100 µM daidzein for 48 h. Among the four isoflavones, only 50 and 100 µM genistin and genistein markedly suppressed lipid accumulation during adipogenesis in 3T3-L1 cells through a similar signaling pathway in a dose-dependent manner. Genistin and genistein suppress adipocyte-specific proteins and genes, such as peroxisome proliferator-activated receptor γ (PPARγ), CCAAT-enhancer-binding protein α (C/EBPα), and adipocyte binding protein 2 (aP2)/fatty acid-binding protein 4 (FABP4), and lipogenic enzymes such as ATP citrate lyase (ACL), acetyl-CoA carboxylase 1 (ACC1), and fatty acid synthase (FAS). Both isoflavones also activate AMP-activated protein kinase α (AMPKα), an essential factor in adipocyte differentiation, and inhibited sterol regulatory element-binding transcription factor 1c (SREBP-1c). These results indicate that genistin is a potent anti-adipogenic and anti-lipogenic agent.

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Pitchford, S. C. "Novel uses for anti-platelet agents as anti-inflammatory drugs." British Journal of Pharmacology 152, no. 7 (December 2007): 987–1002. http://dx.doi.org/10.1038/sj.bjp.0707364.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

21

Trostchansky, A., M. Ferrari, A. Ferreira, D. Abdalla, and H. Rubbo. "NITROARACHIDONATE (AANO2), A NOVEL ANTI-INFLAMMATORY AND ANTI-ATHEROGENIC COMPOUND." Atherosclerosis Supplements 9, no. 1 (May 2008): 170. http://dx.doi.org/10.1016/s1567-5688(08)70684-6.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Saleem, Mohammad. "Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpene." Cancer Letters 285, no. 2 (November 2009): 109–15. http://dx.doi.org/10.1016/j.canlet.2009.04.033.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

23

Herdewijn, Piet A. M. M. "Novel nucleoside strategies for anti-HIV and anti-HSV therapy." Antiviral Research 19, no. 1 (July 1992): 1–14. http://dx.doi.org/10.1016/0166-3542(92)90052-7.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

24

Kapoor, Aniruddh, Philip Vaidyan, Basmah Jalil, and Chitra Upaluri. "Novel case of anti-synthetase syndrome." European Journal of Rheumatology 5, no. 4 (November 27, 2018): 275–77. http://dx.doi.org/10.5152/eurjrheum.2018.17167.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

25

Meyer, Elazar. "Novel dual action anti-neoplastic drugs." Technium BioChemMed 3, no. 2 (July 27, 2022): 120–26. http://dx.doi.org/10.47577/biochemmed.v3i2.6972.

Повний текст джерела

Анотація:

A novel drug structure (a Markush structure) is presented including molecules that can be effective as dual action drugs namely as inhibitors of epidermal growth factor kinase domain as well as having anti-angiogenic activity. The novel Markush structure includes molecules that might have dual anti-neoplastic activity leading to the development of a novel effective cancer drug for treating e.g., pancreatic cancer.

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Ianevski, Aleksandr, Eva Zusinaite, Tanel Tenson, Valentyn Oksenych, Wei Wang, Jan Egil Afset, Magnar Bjørås, and Denis E. Kainov. "Novel Synergistic Anti-Enteroviral Drug Combinations." Viruses 14, no. 9 (August 25, 2022): 1866. http://dx.doi.org/10.3390/v14091866.

Повний текст джерела

Анотація:

Background: Enterovirus infections affect people around the world, causing a range of illnesses, from mild fevers to severe, potentially fatal conditions. There are no approved treatments for enterovirus infections. Methods: We have tested our library of broad-spectrum antiviral agents (BSAs) against echovirus 1 (EV1) in human adenocarcinoma alveolar basal epithelial A549 cells. We also tested combinations of the most active compounds against EV1 in A549 and human immortalized retinal pigment epithelium RPE cells. Results: We confirmed anti-enteroviral activities of pleconaril, rupintrivir, cycloheximide, vemurafenib, remdesivir, emetine, and anisomycin and identified novel synergistic rupintrivir–vemurafenib, vemurafenib–pleconaril and rupintrivir–pleconaril combinations against EV1 infection. Conclusions: Because rupintrivir, vemurafenib, and pleconaril require lower concentrations to inhibit enterovirus replication in vitro when combined, their cocktails may have fewer side effects in vivo and, therefore, should be further explored in preclinical and clinical trials against EV1 and other enterovirus infections.

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Totary-Jain, H., I. Hetherington, I. Wickramage, I. Hortu, and J. Vanwye. "Novel anti-atherosclerotic mRNA-based therapy." Atherosclerosis 355 (August 2022): 27. http://dx.doi.org/10.1016/j.atherosclerosis.2022.06.074.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Kumari, Neeti, and Kiran Godse. "Bepotastine besilate: A novel anti-histamine." Indian Journal of Drugs in Dermatology 3, no. 2 (2017): 64. http://dx.doi.org/10.4103/ijdd.ijdd_22_17.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

29

Shrihari, TG. "Beta-Endorphin - Novel Anti-Tumor Activity." Madridge Journal of Oncogenesis 3, no. 1 (January 7, 2019): 57–58. http://dx.doi.org/10.18689/mjo-1000110.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

30

Sumathi, R., A. Sultan, and S. Syed Shafi. "ANTI-MICROBIAL EVOLUTION OF NOVEL THIAZOLES." Journal of Pharmaceutical & Scientific Innovation 3, no. 2 (April 25, 2014): 139–42. http://dx.doi.org/10.7897/2277-4572.032125.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

31

Sharma, Vikrant, Sonika Sharma, Sanjay Jaiswal, Ravi R. Ghanghas, Durgaprasad Bodepalli, and Ashok Kumar Sharma. "Ertugliflozin: a novel anti-diabetic drug." International Journal of Basic & Clinical Pharmacology 7, no. 12 (November 24, 2018): 2472. http://dx.doi.org/10.18203/2319-2003.ijbcp20184607.

Повний текст джерела

Анотація:

Diabetes Mellitus is a disorder of global proportion. Despite various treatment modalities presently being available, yet the desired glycaemic control and patient outcomes have not been achieved completely. Sodium glucose co-transporter type 2 inhibitors (SGLT2 inhibitors) are one such promising group of emerging drugs in diabetes treatment. Ertugliflozin prevents the reabsorption of glucose by inhibiting sodium-glucose cotransporter-2 (SGLT2) at proximal convoluted tubules. Ertugliflozin is available as 5mg and 15mg tablets. Ertugliflozin has been related to genital mycotic infections and urinary tract infections. Benefits of Ertugliflozin include better control on blood glucose, body weight and blood pressure.

Стилі APA, Harvard, Vancouver, ISO та ін.

32

Nagarkatti, Prakash, Rupal Pandey, Sadiye Amcaoglu Rieder, Venkatesh L. Hegde, and Mitzi Nagarkatti. "Cannabinoids as novel anti-inflammatory drugs." Future Medicinal Chemistry 1, no. 7 (October 2009): 1333–49. http://dx.doi.org/10.4155/fmc.09.93.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

33

Lucamante, Stefania. "The Anti-Illusionist Italian Historical Novel." Forum Italicum: A Journal of Italian Studies 41, no. 1 (March 2007): 219–24. http://dx.doi.org/10.1177/001458580704100113.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

34

Bhowmick, Binita, and Dave Singh. "Novel anti-inflammatory treatments for asthma." Expert Review of Respiratory Medicine 2, no. 5 (October 2008): 617–29. http://dx.doi.org/10.1586/17476348.2.5.617.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

35

Crews, Brian. "Anti-style and the postmodernist novel." Revista Alicantina de Estudios Ingleses, no. 9 (1996): 41–52. http://dx.doi.org/10.14198/raei.1996.9.03.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

36

Feenberg, Anne-Marie. "Max Havelaar: An Anti-imperialist Novel." MLN 112, no. 5 (1997): 817–35. http://dx.doi.org/10.1353/mln.1997.0074.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

37

Kasai, Masaji, and Hitoshi Arai. "Review: Anti-infectives Novel mitomycin derivatives." Expert Opinion on Therapeutic Patents 5, no. 8 (August 1995): 757–70. http://dx.doi.org/10.1517/13543776.5.8.757.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

38

&NA;. "Progress with novel anti-HIV treatments." Inpharma Weekly &NA;, no. 821 (January 1992): 5. http://dx.doi.org/10.2165/00128413-199208210-00010.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

39

Rockenfeller, Patrick, Didac Carmona-Gutierrez, Federico Pietrocola, Guido Kroemer, and Frank Madeo. "Ethanolamine: A novel anti-aging agent." Molecular & Cellular Oncology 3, no. 1 (March 19, 2015): e1019023. http://dx.doi.org/10.1080/23723556.2015.1019023.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

40

Tally, Robert T. "Anti-Ishmael: Novel Beginnings inMoby-Dick." Lit: Literature Interpretation Theory 18, no. 1 (February 27, 2007): 1–19. http://dx.doi.org/10.1080/10436920601174446.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

41

Karbownik, Michał S., and Jerzy Z. Nowak. "Hyaluronan: Towards novel anti-cancer therapeutics." Pharmacological Reports 65, no. 5 (September 2013): 1056–74. http://dx.doi.org/10.1016/s1734-1140(13)71465-8.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

42

Shamsuddin, Abulkalam M., Ivana Vucenik, and Katharine E. Cole. "IP6: A novel anti-cancer agent." Life Sciences 61, no. 4 (June 1997): 343–54. http://dx.doi.org/10.1016/s0024-3205(97)00092-1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

43

Brinner, Kristin M., Jin Mi Kim, Hiromu Habashita, Ilya Y. Gluzman, Daniel E. Goldberg, and Jonathan A. Ellman. "Novel and Potent Anti-malarial Agents." Bioorganic & Medicinal Chemistry 10, no. 11 (November 2002): 3649–61. http://dx.doi.org/10.1016/s0968-0896(02)00207-9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

44

Rainsford, K. D. "Novel non-steroidal anti-inflammatory drugs." Baillière's Clinical Rheumatology 2, no. 2 (August 1988): 485–511. http://dx.doi.org/10.1016/s0950-3579(88)80023-2.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

45

Bhattacharya, Sanjay, and Husam Osman. "Novel targets for anti-retroviral therapy." Journal of Infection 59, no. 6 (December 2009): 377–86. http://dx.doi.org/10.1016/j.jinf.2009.09.014.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

46

Klein, Larry L., Valentina Petukhova, Baojie Wan, Yuehong Wang, Bernard D. Santasiero, David C. Lankin, Guido F. Pauli, and Scott G. Franzblau. "A novel indigoid anti-tuberculosis agent." Bioorganic & Medicinal Chemistry Letters 24, no. 1 (January 2014): 268–70. http://dx.doi.org/10.1016/j.bmcl.2013.11.024.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

47

Anargyrou, Konstantinos, Meletios-Athanassios Dimopoulos, Orhan Sezer, and Evangelos Terpos. "Novel anti-myeloma agents and angiogenesis." Leukemia & Lymphoma 49, no. 4 (January 2008): 677–89. http://dx.doi.org/10.1080/10428190701861686.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

48

Hermann, Matthias, and Frank Ruschitzka. "Novel anti-inflammatory drugs in hypertension." Nephrology Dialysis Transplantation 21, no. 4 (January 23, 2006): 859–64. http://dx.doi.org/10.1093/ndt/gfk054.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

49

Liu, Fu-Tong. "Galectins: novel anti-inflammatory drug targets." Expert Opinion on Therapeutic Targets 6, no. 4 (August 2002): 461–68. http://dx.doi.org/10.1517/14728222.6.4.461.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

50

van der Valk, Fleur M., Diederik F. van Wijk, and Erik S. G. Stroes. "Novel anti-inflammatory strategies in atherosclerosis." Current Opinion in Lipidology 23, no. 6 (December 2012): 532–39. http://dx.doi.org/10.1097/mol.0b013e3283587543.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!